List of insiders holdings for KIORA PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Ventech Capital II 10% Owner |
2017-06-16 16:48:28 | 2,773,718 0 |
2,773,718 | Form 13D |
| 2 | IPSA (INNOVEN PARTENAIRES S.A.) 10% Owner |
2018-01-17 16:15:14 | 770,065 0 |
770,065 | Form 13D |
| 3 | NATIXIS PRIVATE EQUITY 10% Owner |
2017-06-16 16:30:47 | 612,317 0 |
612,317 | Form 13G |
| 4 | Wirostko Barbara Chief Medical Officer |
2019-08-07 19:20:48 | 403,893 59,915 |
463,808 | Form 4 |
| 5 | Garanzini Michael Chief Commercial Officer |
2018-07-12 17:04:07 | 196,250 0 |
196,250 | Form 4 |
| 6 | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
2023-02-14 13:01:57 | 89,997 0 |
89,997 | Form 13G |
| 7 | Strem Brian M. President and CEO |
2025-04-02 20:28:23 | 77,986 0 |
77,986 | Form 4 |
| 8 | FROM STEPHEN Executive Chairman |
2022-01-06 17:10:17 | 67,693 0 |
67,693 | Form 4 |
| 9 | Greenleaf Peter Director |
2019-02-05 16:39:17 | 50,000 0 |
50,000 | Form 4 |
| 10 | Daniels Eric Joseph Chief Development Officer |
2025-04-02 20:28:59 | 41,918 0 |
41,918 | Form 4 |
| 11 | Tosca Melissa CFO |
2025-04-02 20:29:26 | 36,914 0 |
36,914 | Form 4 |
| 12 | Obermayr Franz Acting CEO |
2021-02-03 21:50:48 | 30,000 0 |
30,000 | Form 4 |
| 13 | TYLE PRAVEEN Director |
2025-04-02 20:14:32 | 30,000 0 |
30,000 | Form 4 |
| 14 | Romano Sarah Chief Financial Officer |
2022-02-11 16:31:07 | 22,746 0 |
22,746 | Form 4 |
| 15 | Shapiro Aron Director |
2025-04-02 20:16:32 | 20,000 0 |
20,000 | Form 4 |
| 16 | Parsons Erin Director |
2025-04-02 20:15:58 | 20,000 0 |
20,000 | Form 4 |
| 17 | Hollander David Director |
2025-04-02 20:15:08 | 20,000 0 |
20,000 | Form 4 |
| 18 | Walters-Hoffert Lisa Director |
2025-04-02 20:10:40 | 20,000 0 |
20,000 | Form 4 |
| 19 | Stengone Carmine N. Director |
2025-04-02 20:11:50 | 20,000 0 |
20,000 | Form 4 |
| 20 | MANZO MICHAEL P. VP of Engineering |
2021-08-04 17:46:17 | 15,378 0 |
15,378 | Form 4 |
| 21 | Mann Brenda VP of Research & Development |
2021-11-03 16:16:00 | 15,136 0 |
15,136 | Form 4 |
| 22 | BALLAND THOMAS Director |
2017-06-22 16:19:30 | 15,000 0 |
15,000 | Form 4 |
| 23 | CHANEY PAUL G Director |
2023-03-07 20:13:28 | 8,000 0 |
8,000 | Form 4 |
| 24 | Gayron Kenneth L Director |
2023-10-03 16:44:02 | 5,000 0 |
5,000 | Form 4 |
| 25 | Brenneman Ryan Randall Chief Financial Officer |
2016-07-19 17:49:32 | 4,568 0 |
4,568 | Form 4 |
| 26 | GOLDBERG MORTON Director |
2021-02-03 21:51:44 | 3,333 0 |
3,333 | Form 4 |
| 27 | HANCOCK THOMAS Director |
2021-02-03 21:52:35 | 3,333 0 |
3,333 | Form 4 |
| 28 | MALFROY-CAMINE BERNARD Director |
2021-02-03 21:51:57 | 3,333 0 |
3,333 | Form 4 |
| 29 | Chaoui Mounia Director |
2016-03-31 17:02:52 | 2,416 0 |
2,416 | Form 4 |
| 30 | Drexler Susan L. Interim CFO |
2022-05-02 18:38:41 | 0 0 |
0 | Form 3 |
| 31 | Maher Illya Keith Director |
2020-01-15 17:45:59 | 0 0 |
0 | Form 3 |
| 32 | FCPR VENTECH B 10% Owner |
2015-02-23 17:45:31 | 0 0 |
0 | Form 4 |